Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-22

Clinical Trial Update: Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of levalbuterol versus racemic albuterol in asthma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levalbuterol (Levalbuterol)
  • Racemic albuterol (albuterol (racemic))

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED